0 items USD 0.00Search
Your search for "current partnering idiopathic pulmonary fibrosis partnering 2009 2014" gave back 57295 results.
The global Idiopathic Pulmonary Fibrosis Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Idiopathic...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The “Idiopathic Pulmonary Fibrosis Drug Industry Forecast” looks at past sales and reviews total world Idiopathic Pulmonary Fibrosis Drug sales in...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Idiopathic Pulmonary Fibrosis Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
These include nintedanib (Ofev®) and pirfenidone (Esbriet®). These medications are called anti-fibrotic agents, meaning that they have shown in...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Highlights The global Idiopathic Pulmonary Fibrosis Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Idiopathic Pulmonary Fibrosis Treatment is treatment work on a lung disease which causes the tissue in your lungs to become stiff. The global...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Idiopathic Pulmonary Fibrosis (IPF) Drugs market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Idiopathic pulmonary fibrosis is a condition in which the tissues in the lungs become thick and stiff over time. As a result of thickening of lung...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Idiopathic pulmonary fibrosis is a condition in which the tissues in the lungs become thick and stiff over time. As a result of thickening of lung...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Highlights The global Idiopathic Pulmonary Fibrosis Treatment Drug market is projected to reach US$ million by 2028 from an estimated US$ million in...
Catalog:
MRRPB5
January 2023
Price: USD 2,900.00
Idiopathic Pulmonary Fibrosis Treatment is treatment work on a lung disease which causes the tissue in your lungs to become stiff. Highlights The...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Idiopathic Pulmonary Fibrosis (IPF) Drug market will...
Catalog:
Arsta
May 2023
Price: USD 4,350.00
Idiopathic Pulmonary Fibrosis Treatment is treatment work on a lung disease which causes the tissue in your lungs to become stiff. The “Idiopathic...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Idiopathic pulmonary fibrosis (Idiopathic pulmonary fibrosis, IPF) is a rare, chronic, and fatal disease that will gradually develop over a period of...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Idiopathic Pulmonary Fibrosis Treatment Drug market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
